D-0939-2022 Class II

Recalled by Olympia Compounding Pharmacy Dba Olympia Pharmacy — Orlando, FL

FDA drug recall D-0939-2022 was initiated by Olympia Compounding Pharmacy Dba Olympia Pharmacy on May 9, 2022 and is designated Class II. Reason for recall: Lack of assurance of sterility. Affected quantity: 8982 vials.

Recall Details

Product Type
Drugs
Report Date
Jun 1, 2022
Initiation Date
May 9, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8982 vials

Product Description

NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0083-00.

Reason for Recall

Lack of assurance of sterility.

Distribution Pattern

Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands

Code Information

Lots: A2401422 BUD: 1/14/2023, K41001 BUD: 11/1/2022, K41130 BUD: 11/30/2022, L24113 BUD: 12/13/2022, L41102 BUD: 12/2/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0939-2022
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.